http://intranet.chua.local/?optionId=3.4&id=3047
quinta-feira, 14 de novembro de 2019
Dia Mundial da Prematuridade 17 novembro
http://intranet.chua.local/?optionId=3.4&id=3047
Lifesaving
segunda-feira, 6 de outubro de 2014
Reanimar em neonatologia,um procedimento ético?
segunda-feira, 17 de fevereiro de 2014
Projeto «Pequenos Pés, Grandes Passos» apoiado pela Missão Sorriso
Representaram o serviço para receberem o prémio a enf. chefe Fátima Maia e enf. Elsa Silva e a diretora de serviço Maria José Castro.
sexta-feira, 6 de setembro de 2013
Alimentação do Recem Nascido pré termo: Que método de transição para a via oral?
terça-feira, 25 de junho de 2013
NIDCAP na UCINP do Hospital de Faro
http://www.nidcap.org/pdf/NIDCAP-DO-Vol6-No1.pdf
terça-feira, 10 de abril de 2012
Empiric Antifungal Therapy and Outcomes in Extremely Low Birth Weight Infants with Invasive Candidiasis
- Rachel G. Greenberg, MD
, - Daniel K. Benjamin Jr., MD, PhD, MPH
, - Marie G. Gantz, PhD
, - C. Michael Cotten, MD
, - Barbara J. Stoll, MD
, - Michele C. Walsh, MD
, - Pablo J. Sánchez, MD
, - Seetha Shankaran, MD
, - Abhik Das, PhD
, - Rosemary D. Higgins, MD
, - Nancy A. Miller, RN
, - Kathy J. Auten, MSHS
, - Thomas J. Walsh, MD
, - Abbot R. Laptook, MD
, - Waldemar A. Carlo, MD
, - Kathleen A. Kennedy, MD, MPH
, - Neil N. Finer, MD
, - Shahnaz Duara, MD
, - Kurt Schibler, MD
, - Richard A. Ehrenkranz, MD
, - Krisa P. Van Meurs, MD
, - Ivan D. Frantz III, MD
, - Dale L. Phelps, MD
, - Brenda B. Poindexter, MD
,- Edward F. Bell, MD
, - T. Michael O'Shea, MD, MPH
, - Kristi L. Watterberg, MD
, - Ronald N. Goldberg, MD
, - P. Brian Smith, MD, MPH, MHS
, - Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network
Abstract
Objective
To assess the impact of empiric antifungal therapy for invasive candidiasis on subsequent outcomes in premature infants.
Study design
This was a cohort study of infants with a birth weight ≤1000 g receiving care at Neonatal Research Network sites. All infants had at least one positive culture for Candida. Empiric antifungal therapy was defined as receipt of a systemic antifungal on the day of or the day before the first positive culture for Candida was drawn. We created Cox proportional hazards and logistic regression models stratified on propensity score quartiles to determine the effect of empiric antifungal therapy on survival, time to clearance of infection, retinopathy of prematurity, bronchopulmonary dysplasia, end-organ damage, and neurodevelopmental impairment (NDI).
Results
A total of 136 infants developed invasive candidiasis. The incidence of death or NDI was lower in infants who received empiric antifungal therapy (19 of 38; 50%) compared with those who had not (55 of 86; 64%; OR, 0.27; 95% CI, 0.08-0.86). There was no significant difference between the groups for any single outcome or other combined outcomes.
Conclusion
Empiric antifungal therapy was associated with increased survival without NDI. A prospective randomized trial of this strategy is warranted.
Recuperado em 2012, Abril 10. Disponível em
Intermittent Better Than Continuous for Nasal Ventilation in Preemies
A Systematic Review and Meta-analysis
Arch Pediatr Adolesc Med. 2012;166(4):372-376. doi:10.1001/archpediatrics.2011.1142
Objective To determine among preterm infants with respiratory distress syndrome whether the use of early nasal intermittent positive-pressure ventilation (NIPPV) vs nasal continuous positive airway pressure (NCPAP) decreases the need for invasive ventilation within the first 72 hours of life.
Data Sources MEDLINE, EMBASE, CINAHL, Cochrane Central Register of Controlled Trials, and clinicaltrials.gov were searched, as well as abstracts from meetings of the Pediatric Academic Societies.
Study Selection Randomized controlled trials involving infants with respiratory distress syndrome who received NIPPV vs NCPAP.
Data Extraction Data were extracted on the use of NIPPV vs NCPAP. Also extracted were data on the need for invasive ventilation within the first 72 hours of life and the incidences of bronchopulmonary dysplasia, pneumothorax, necrotizing enterocolitis, and intraventricular hemorrhage, as well as the time to full feeds and the duration of hospital stay.
Data Synthesis Three trials were included (n = 360). A significant decrease in the need for invasive ventilation was found in the NIPPV group (risk ratio, 0.60; 95% CI, 0.43-0.83). No difference between groups was found in the incidence of bronchopulmonary dysplasia (risk ratio, 0.56; 95% CI, 0.09-3.49). No differences in the other outcomes were observed between the 2 groups.
Conclusions Among preterm infants with respiratory distress syndrome, NIPPV decreases the need for invasive ventilation within the first 72 hours of life compared with NCPAP. Trials are needed to assess whether NIPPV minimizes the occurrence of bronchopulmonary dysplasia and other comorbidities.
Recuperado em 2012, Abril 10. Disponível em
quinta-feira, 17 de novembro de 2011
Dia Internacional de Sensibilização para a Prematuridade
segunda-feira, 26 de setembro de 2011
National Survey of Neonatal Transport Teams in the United States
- Recuperado em 2011, Setembro 26. Disponível em
Objective: Neonatal transport in the United States is a complex process; however, little is known about the neonatal transport team (NTT) workforce. The purpose of this national study was to describe the US NTT workforce.
Participants and Methods: An exploratory, descriptive design that used a Web-based survey questionnaire was used. We identified 398 NTTs, and 345 (86.7%) were enrolled. One survey was completed per team.
Results: Ten NTTs did not complete the survey (response rate: 84.2%). Of the 335 completed surveys, 229 (68.4%) were from unit-based teams and 106 (31.6%) were from dedicated teams. Twenty-six different NTT compositions were used. All except 1 (n = 334) had a registered nurse or a neonatal nurse practitioner as a team member. A registered nurse–respiratory therapist team composition was the most common for unit-based (40.2%) and dedicated (44.3%) teams. Dedicated teams used rotor and fixed-wing modes of travel more frequently, transported further distances, and had higher transport volumes than unit-based teams. The median transport volumes reported suggest that as many as 68 797 critically ill neonates are transported each year.
Conclusions: There is wide variation in many aspects of neonatal transport, including orientation, determination of readiness for independent transport, use of protocols to guide transport care, and quality assurance activities. These results will be useful for (1) evaluating existing transport services, (2) guiding necessary changes in training or services, and (3) aiding programs that seek to develop a neonatal transport program.
-Author Affiliations
- aPrimary Childrens Medical Center, Salt Lake City, Utah;
- bIndiana University School of Medicine, James Whitcomb Riley Hospital for Children, Indianapolis, Indiana;
- cMaryland Regional Neonatal Transport Program, Johns Hopkins Hospital, University of Maryland Medical Center, Baltimore, Maryland; and
- dCollege of Nursing, University of Utah, Salt Lake City, Utah